After the IT sector it was the pharmaceutical sector which came into limelight as another big exporter from India. The valuations exploded and for a decade, pharma stocks were big wealth creators and also strong out performers. However, post 2014, both in terms of bottomline and stock price performance, pharma stocks had been under pressure. On the operating front, USFDA inspection became a major headache and there was pricing pressure in
